Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Genprex, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 72 | 59 | −13 |
| Shares | 8.22M | 5.82M | −2.40M (−29.2%) |
| Value | $35.4M | $19.5M | −$15.9M (−45.0%) |
New holders (12)
Institutions that held Genprex, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 133,000 | $446.0K | 0.01% |
| Tibra Equities Europe Ltd | 95,100 | $319.0K | 0.10% |
| HRT Financial LP | 83,054 | $278.0K | 0.00% |
| Dimensional Fund Advisors LP | 42,390 | $142.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 28,387 | $95.0K | 0.00% |
| Jump Financial, LLC | 26,900 | $90.0K | 0.01% |
| ExodusPoint Capital Management, LP | 25,728 | $86.0K | 0.00% |
| XTX Topco Ltd | 23,604 | $79.0K | 0.03% |
| LMR Partners LLP | 16,035 | $54.0K | 0.00% |
| Boothbay Fund Management, LLC | 11,519 | $39.0K | 0.00% |
| Advisory Services Network, LLC | 1,100 | $4.00K | 0.00% |
| Eaton Vance Management | 107 | $0 | 0.00% |
Sold out (25)
Institutions that held Genprex, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.